Enteric administration of anisodamine in the treatment of hemorrhagic shock.
D000818:Animals; D002402:Cathepsin D / Q000378:metabolism; D002415:Cats; D007413:Intestinal Mucosa / Q000187:drug effects; D008247:Lysosomes / Q000187:drug effects; D008297:Male; D012771:Shock, Hemorrhagic / Q000188:drug therapy*; D012991:Solanaceous Alkaloids / Q000008:administration & dosage*; D014665:Vasodilator Agents / Q000008:administration & dosage*
D012991:Solanaceous Alkaloids; D014665:Vasodilator Agents; C003922:anisodamine; D002402:Cathepsin D